Cargando…

An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective spf/ash Mouse Model of Ornithine Transcarbamylase Deficiency

OTC splicing mutations are generally associated with the severest and early disease onset of ornithine transcarbamylase deficiency (OTCD), the most common urea cycle disorder. Noticeably, splicing defects can be rescued by spliceosomal U1snRNA variants, which showed their efficacy in cellular and an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balestra, Dario, Ferrarese, Mattia, Lombardi, Silvia, Ziliotto, Nicole, Branchini, Alessio, Petersen, Naomi, Bosma, Piter, Pinotti, Mirko, van de Graaf, Stan F. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699343/ https://www.ncbi.nlm.nih.gov/pubmed/33228018 http://dx.doi.org/10.3390/ijms21228735

Ejemplares similares

An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A
por: Balestra, Dario, et al.
Publicado: (2019)

Effect of Ornithine Transcarbamylase (OTC) Deficiency on Pregnancy and Puerperium
por: Sysák, Rastislav, et al.
Publicado: (2022)

Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency
por: Li, Sitao, et al.
Publicado: (2018)

Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector
por: De Sabbata, Giulia, et al.
Publicado: (2020)

Late-Onset Ornithine Transcarbamylase Deficiency and Variable Phenotypes in Vietnamese Females With OTC Mutations
por: Nguyen, Huy-Hoang, et al.
Publicado: (2020)

Hemizygous deletion in the OTC gene results in ornithine transcarbamylase deficiency: A case report
por: Wang, Li-Ping, et al.
Publicado: (2022)

Functional Characterization of the spf/ash Splicing Variation in OTC Deficiency of Mice and Man
por: Rivera-Barahona, Ana, et al.
Publicado: (2015)

Correction: Functional Characterization of the spf/ash Splicing Variation in OTC Deficiency of Mice and Man
por: Rivera-Barahona, Ana, et al.
Publicado: (2015)

Antepartum Ornithine Transcarbamylase Deficiency
por: Nakajima, Hitoshi, et al.
Publicado: (2014)

OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spf(ash) mice, and govern susceptibility to RNA-based therapies
por: Sacchetto, Claudia, et al.
Publicado: (2021)

A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I
por: Balestra, Dario, et al.
Publicado: (2020)

Mutation Study of Malaysian Patients with Ornithine Transcarbamylase Deficiency: Clinical, Molecular, and Bioinformatics Analyses of Two Novel Missense Mutations of the OTC Gene
por: Ali, Ernie Zuraida, et al.
Publicado: (2018)

Ornithine Transcarbamylase – From Structure to Metabolism: An Update
por: Couchet, Morgane, et al.
Publicado: (2021)

Ornithine transcarbamylase deficiency: A diagnostic odyssey
por: Knerr, Ina, et al.
Publicado: (2022)

Three-Country Snapshot of Ornithine Transcarbamylase Deficiency
por: Seker Yilmaz, Berna, et al.
Publicado: (2022)

Genetic Therapy Approaches for Ornithine Transcarbamylase Deficiency
por: Seker Yilmaz, Berna, et al.
Publicado: (2023)

A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation
por: Surjan, Rodrigo C., et al.
Publicado: (2017)

Sustained Correction of OTC Deficiency in Spf (ash) mice Using Optimized Self-complementary AAV2/8 Vectors
por: Wang, Lili, et al.
Publicado: (2011)

Hyperammonemic Coma in an Adult due to Ornithine Transcarbamylase Deficiency
por: Roberts, Daniel L., et al.
Publicado: (2013)

Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency
por: Cheng, Lin, et al.
Publicado: (2019)

Challenges of managing ornithine transcarbamylase deficiency in female heterozygotes()
por: Feigenbaum, Annette
Publicado: (2022)

A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation
por: Tarasenko, Tatyana N., et al.
Publicado: (2015)

Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma
por: He, Lin, et al.
Publicado: (2019)

Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency
por: Koya, Yudai, et al.
Publicado: (2018)

Hyperammonaemic Encephalopathy Caused by Adult-Onset Ornithine Transcarbamylase Deficiency
por: Niclasen, Bjarke Hammer, et al.
Publicado: (2022)

Acute Fulminant Encephalopathy in an Adult due to Ornithine Transcarbamylase Deficiency
por: Nambiar, Vivek K., et al.
Publicado: (2022)

Predicting the disease severity in male individuals with ornithine transcarbamylase deficiency
por: Scharre, Svenja, et al.
Publicado: (2022)

Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD)
por: Laemmle, Alexander, et al.
Publicado: (2016)

Computational pipeline to identify and characterize functional mutations in ornithine transcarbamylase deficiency
por: Magesh, R., et al.
Publicado: (2014)

Characterization and Treatment Responsiveness of Genetically Engineered Ornithine Transcarbamylase-Deficient Pig
por: Enosawa, Shin, et al.
Publicado: (2021)

Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency
por: Lu, Deyun, et al.
Publicado: (2020)

Transient Cortical Blindness in a Toddler With Heterozygous Ornithine Transcarbamylase Deficiency
por: Eskander, Peter N, et al.
Publicado: (2021)

Ornithine Transcarbamylase Deficiency Presenting as Acute Encephalopathy After Strabismus Surgery
por: Lung, John, et al.
Publicado: (2022)

Ornithine transcarbamylase deficiency and pregnancy: A case series and review of recommendations
por: Pinho, Gabriella, et al.
Publicado: (2022)

Diagnostic and Management Issues in Patients with Late-Onset Ornithine Transcarbamylase Deficiency
por: Ibrahim, Majitha Seyed, et al.
Publicado: (2023)

Acute fatal presentation of ornithine transcarbamylase deficiency in a previously healthy male
por: Klein, Ophir D., et al.
Publicado: (2008)

Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients
por: Brassier, Anais, et al.
Publicado: (2015)

Severe Hyperammonemia in Late-Onset Ornithine Transcarbamylase Deficiency Triggered by Steroid Administration
por: Gascon-Bayarri, Jordi, et al.
Publicado: (2015)

A novel mutation in ornithine transcarbamylase gene causing mild intermittent hyperammonemia
por: Mohamed, Sarar, et al.
Publicado: (2015)

Late-onset ornithine transcarbamylase deficiency: An under recognized cause of metabolic encephalopathy
por: Rush, Eric T, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rsqhsnv30g8qa76kkkvogm3eth